Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
US Department of Justice
Fuji
Teva
Novartis
Daiichi Sankyo
Citi
Farmers Insurance
Boehringer Ingelheim
Medtronic

Generated: February 21, 2018

DrugPatentWatch Database Preview

Ferric carboxymaltose - Generic Drug Details

« Back to Dashboard

What are the generic sources for ferric carboxymaltose and what is the scope of ferric carboxymaltose patent protection?

Ferric carboxymaltose
is the generic ingredient in one branded drug marketed by Luitpold Pharms Inc and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ferric carboxymaltose has sixty-six patent family members in thirty-one countries.

There are fifteen drug master file entries for ferric carboxymaltose. One supplier is listed for this compound.
Summary for ferric carboxymaltose
International Patents:66
US Patents:4
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 15
Suppliers / Packagers: 1
Bulk Api Vendors: 1
Clinical Trials: 143
Drug Prices:see low prices
DailyMed Link:ferric carboxymaltose at DailyMed
Pharmacology for ferric carboxymaltose

US Patents and Regulatory Information for ferric carboxymaltose

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Luitpold Pharms Inc INJECTAFER ferric carboxymaltose INJECTABLE;INTRAVENOUS 203565-001 Jul 25, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Luitpold Pharms Inc INJECTAFER ferric carboxymaltose INJECTABLE;INTRAVENOUS 203565-001 Jul 25, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Luitpold Pharms Inc INJECTAFER ferric carboxymaltose INJECTABLE;INTRAVENOUS 203565-001 Jul 25, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Luitpold Pharms Inc INJECTAFER ferric carboxymaltose INJECTABLE;INTRAVENOUS 203565-001 Jul 25, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for ferric carboxymaltose

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,431,549 Methods and compositions for administration of iron ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for ferric carboxymaltose

Country Document Number Estimated Expiration
Canada 2635894 ➤ Sign Up
Norway 335770 ➤ Sign Up
Portugal 1554315 ➤ Sign Up
Denmark 1973549 ➤ Sign Up
Norway 20110654 ➤ Sign Up
Denmark 2287204 ➤ Sign Up
South Korea 100992178 ➤ Sign Up
Hungary E029259 ➤ Sign Up
Cyprus 1118780 ➤ Sign Up
Israel 166747 ➤ Sign Up
Country Document Number Estimated Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Colorcon
Argus Health
Cerilliant
Johnson and Johnson
US Department of Justice
Baxter
Fish and Richardson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot